News Release

One-year adverse outcomes among adults with long COVID vs those without COVID-19

JAMA Health Forum

Peer-Reviewed Publication

JAMA Network

About The Study: This case-control study leveraged a large commercial insurance database and found increased rates of adverse outcomes over a 1-year period for a post–COVID-19 condition (long COVID) cohort surviving the acute phase of illness. The results indicate a need for continued monitoring for at-risk individuals, particularly in the area of cardiovascular and pulmonary management. 

Authors: Andrea DeVries, Ph.D., of Elevance Health, Inc., in Indianapolis, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamahealthforum.2023.0010)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2023.0010?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=030323

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.